Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID 19 outpatients meta-analysis

CoV-Early (Gharbharan)
  NCT04589949		 RCTconvalescent plasma treatmentplaceboCOVID 19 outpatientslow
207/209 inconclusive
    CONV-ERT
          NCT04621123    		 RCTconvalescent plasma treatmentplaceboCOVID 19 outpatientslow
    		188/160 inconclusive
      C3PO
              NCT04355767      		 RCTconvalescent plasma treatmentplaceboCOVID 19 outpatientssome concern
      		257/254 inconclusive
      • inconclusive 9 % decrease in hospitalization or death (PE) with a moderate degree of certainty due to some concern in risk of bias

      PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
      Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).

       

      - About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons